Synagis®: Spread the word about RSV protection with tell-a-friend ecards

What's one of the best ways to help prevent severe RSV disease? Help your friends and family learn more about RSV protection. Use the e-cards below to spread the word about all of the RSV information and resources on Synagis.com.

You can preview all of the messages by clicking on the different choices below. Once you've picked an e-card, fill out the form at the bottom of the page and click submit.

E-Card 1 E-Card 2 E-Card 3 Thrive E-Card

* Indicates required field

* Your first name:

* Your last name:

* Your e-mail address:

* Friend's e-mail address:

Friend's e-mail address: (optional)

We will not save your e-mail address or your friend’s e-mail address. We will only use it to send the e-card you request.

We will send you a copy of this e-mail.

You may send each message to up to 3 people at a time.

Important Safety Information

Synagis® (palivizumab) is indicated for the prevention of serious lung infections caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease. Synagis is given as a shot, usually in the thigh muscle, each month during the RSV season. The first dose of Synagis should be given before RSV season begins. Children who develop an RSV infection while receiving Synagis should continue the monthly dosing schedule throughout the season. Synagis has been used in more than one million children in the U.S. since its introduction in 1998.

Very rare cases (<1 per 100,000 patients) of severe allergic reactions such as anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. These rare reactions may occur when any dose of Synagis is given, not just the first one. Also, rare but serious side effects can occur, which may lead to unusual bruising and/or groups of pinpoint red spots found on the skin.

Other side effects with Synagis may include upper respiratory tract infection, ear infection, fever, and runny nose. In children born with heart problems, Synagis was associated with reports of low blood oxygen levels and abnormal heart rhythms. Synagis should not be used in patients with a history of a severe prior reaction to Synagis or its components. Side effects, such as, skin reactions around the area where the shot was given (like redness, swelling, warmth, or discomfort) can also occur.